miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer
Estrogen receptor-α (ERα) is essential for estrogen-dependent growth and its level of expression is a crucial determinant of response to endocrine therapy and prognosis in ERα-positive breast cancer. Breast cancer patients show a wide range of ERα expression levels which change in individual patient...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
D.A. Spandidos
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570195/ |